Neogen (NEOG) Revenue Growth (3y) (2013 - 2026)
Neogen (NEOG) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 0.73% |
| 10 | Neogen | 2.05 Bn | 1.89 Bn | 99.00 Mn | -1.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.09% |
| Nov 30, 2025 | -0.78% |
| Aug 31, 2025 | 16.49% |
| May 31, 2025 | 17.19% |
| Feb 28, 2025 | 19.89% |
| Nov 30, 2024 | 21.01% |
| Aug 31, 2024 | 19.14% |
| May 31, 2024 | 22.94% |
| Feb 29, 2024 | 25.16% |
| Nov 30, 2023 | 25.92% |
| Aug 31, 2023 | 27.95% |
| May 31, 2023 | 30.39% |
| Feb 28, 2023 | 29.77% |
| Nov 30, 2022 | 28.74% |
| Aug 31, 2022 | 9.28% |
| May 31, 2022 | 8.47% |
| Feb 28, 2022 | 9.49% |
| Nov 30, 2021 | 6.81% |
| Aug 31, 2021 | 8.80% |
| May 31, 2021 | 5.63% |